These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 9058789

  • 1. Abnormal CD40-mediated activation pathway in B lymphocytes from patients with hyper-IgM syndrome and normal CD40 ligand expression.
    Durandy A, Hivroz C, Mazerolles F, Schiff C, Bernard F, Jouanguy E, Revy P, DiSanto JP, Gauchat JF, Bonnefoy JY, Casanova JL, Fischer A.
    J Immunol; 1997 Mar 15; 158(6):2576-84. PubMed ID: 9058789
    [Abstract] [Full Text] [Related]

  • 2. Induction by anti-CD40 antibody or soluble CD40 ligand and cytokines of IgG, IgA and IgE production by B cells from patients with X-linked hyper IgM syndrome.
    Durandy A, Schiff C, Bonnefoy JY, Forveille M, Rousset F, Mazzei G, Milili M, Fischer A.
    Eur J Immunol; 1993 Sep 15; 23(9):2294-9. PubMed ID: 7690328
    [Abstract] [Full Text] [Related]

  • 3. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
    Eliopoulos AG, Stack M, Dawson CW, Kaye KM, Hodgkin L, Sihota S, Rowe M, Young LS.
    Oncogene; 1997 Jun 19; 14(24):2899-916. PubMed ID: 9205097
    [Abstract] [Full Text] [Related]

  • 4. Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features.
    Lougaris V, Badolato R, Ferrari S, Plebani A.
    Immunol Rev; 2005 Feb 19; 203():48-66. PubMed ID: 15661021
    [Abstract] [Full Text] [Related]

  • 5. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction.
    Klaus SJ, Pinchuk LM, Ochs HD, Law CL, Fanslow WC, Armitage RJ, Clark EA.
    J Immunol; 1994 Jun 15; 152(12):5643-52. PubMed ID: 7515910
    [Abstract] [Full Text] [Related]

  • 6. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer.
    Subauste CS, Wessendarp M, Sorensen RU, Leiva LE.
    J Immunol; 1999 Jun 01; 162(11):6690-700. PubMed ID: 10352287
    [Abstract] [Full Text] [Related]

  • 7. Specific NEMO mutations impair CD40-mediated c-Rel activation and B cell terminal differentiation.
    Jain A, Ma CA, Lopez-Granados E, Means G, Brady W, Orange JS, Liu S, Holland S, Derry JM.
    J Clin Invest; 2004 Dec 01; 114(11):1593-602. PubMed ID: 15578091
    [Abstract] [Full Text] [Related]

  • 8. Absence of IgD-CD27(+) memory B cell population in X-linked hyper-IgM syndrome.
    Agematsu K, Nagumo H, Shinozaki K, Hokibara S, Yasui K, Terada K, Kawamura N, Toba T, Nonoyama S, Ochs HD, Komiyama A.
    J Clin Invest; 1998 Aug 15; 102(4):853-60. PubMed ID: 9710455
    [Abstract] [Full Text] [Related]

  • 9. Hyper IgM syndrome associated with defective CD40-mediated B cell activation.
    Conley ME, Larché M, Bonagura VR, Lawton AR, Buckley RH, Fu SM, Coustan-Smith E, Herrod HG, Campana D.
    J Clin Invest; 1994 Oct 15; 94(4):1404-9. PubMed ID: 7523449
    [Abstract] [Full Text] [Related]

  • 10. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.
    Hauer J, Püschner S, Ramakrishnan P, Simon U, Bongers M, Federle C, Engelmann H.
    Proc Natl Acad Sci U S A; 2005 Feb 22; 102(8):2874-9. PubMed ID: 15708970
    [Abstract] [Full Text] [Related]

  • 11. TNF receptor-associated factor-3 signaling mediates activation of p38 and Jun N-terminal kinase, cytokine secretion, and Ig production following ligation of CD40 on human B cells.
    Grammer AC, Swantek JL, McFarland RD, Miura Y, Geppert T, Lipsky PE.
    J Immunol; 1998 Aug 01; 161(3):1183-93. PubMed ID: 9686578
    [Abstract] [Full Text] [Related]

  • 12. CD40, but not lipopolysaccharide and anti-IgM stimulation of primary B lymphocytes, leads to a persistent nuclear accumulation of RelB.
    Neumann M, Wohlleben G, Chuvpilo S, Kistler B, Wirth T, Serfling E, Schimpl A.
    J Immunol; 1996 Dec 01; 157(11):4862-9. PubMed ID: 8943389
    [Abstract] [Full Text] [Related]

  • 13. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM.
    Korthäuer U, Graf D, Mages HW, Brière F, Padayachee M, Malcolm S, Ugazio AG, Notarangelo LD, Levinsky RJ, Kroczek RA.
    Nature; 1993 Feb 11; 361(6412):539-41. PubMed ID: 7679206
    [Abstract] [Full Text] [Related]

  • 14. Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborns.
    Durandy A, De Saint Basile G, Lisowska-Grospierre B, Gauchat JF, Forveille M, Kroczek RA, Bonnefoy JY, Fischer A.
    J Immunol; 1995 Feb 15; 154(4):1560-8. PubMed ID: 7530739
    [Abstract] [Full Text] [Related]

  • 15. Signaling through CD40 rescues IgE but not IgG or IgA secretion in X-linked immunodeficiency with hyper-IgM.
    Saiki O, Tanaka T, Wada Y, Uda H, Inoue A, Katada Y, Izeki M, Iwata M, Nunoi H, Matsuda I.
    J Clin Invest; 1995 Feb 15; 95(2):510-4. PubMed ID: 7532185
    [Abstract] [Full Text] [Related]

  • 16. CD40 ligand (CD40L) expression and B cell function in agammaglobulinemia with normal or elevated levels of IgM (HIM). Comparison of X-linked, autosomal recessive, and non-X-linked forms of the disease, and obligate carriers.
    Callard RE, Smith SH, Herbert J, Morgan G, Padayachee M, Lederman S, Chess L, Kroczek RA, Fanslow WC, Armitage RJ.
    J Immunol; 1994 Oct 01; 153(7):3295-306. PubMed ID: 7916370
    [Abstract] [Full Text] [Related]

  • 17. CD40 ligand-CD40 interaction in Ig isotype switching in mature and immature human B cells.
    Aversa G, Punnonen J, Carballido JM, Cocks BG, de Vries JE.
    Semin Immunol; 1994 Oct 01; 6(5):295-301. PubMed ID: 7532459
    [Abstract] [Full Text] [Related]

  • 18. Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination.
    Imai K, Catalan N, Plebani A, Maródi L, Sanal O, Kumaki S, Nagendran V, Wood P, Glastre C, Sarrot-Reynauld F, Hermine O, Forveille M, Revy P, Fischer A, Durandy A.
    J Clin Invest; 2003 Jul 01; 112(1):136-42. PubMed ID: 12840068
    [Abstract] [Full Text] [Related]

  • 19. Lymphoid abnormalities in CD40 ligand transgenic mice suggest the need for tight regulation in gene therapy approaches to hyper immunoglobulin M (IgM) syndrome.
    Sacco MG, Ungari M, Catò EM, Villa A, Strina D, Notarangelo LD, Jonkers J, Zecca L, Facchetti F, Vezzoni P.
    Cancer Gene Ther; 2000 Oct 01; 7(10):1299-306. PubMed ID: 11059686
    [Abstract] [Full Text] [Related]

  • 20. Pairs of surface molecules involved in human IgE regulation: CD23-CD21 and CD40-CD40L.
    Bonnefoy JY, Gauchat JF, Life P, Graber P, Mazzei G, Aubry JP.
    Eur Respir J Suppl; 1996 Aug 01; 22():63s-66s. PubMed ID: 8871046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.